human-human hybridoma technology was used to immortalize human b lymphocytes from patients with acute myeloid leukemia ( aml ) to study the antigenic repertoire of the humoral immune response against the patients ' own leukemia cells and against leukemic cells from other patients .
C0003320
antigenic
C0020967
humoral immune response